Genetic analyses of the lupus-prone NZM2410 mouse have identified multiple susceptibility loci on chromosome 7, termed Sle3 and Sle5. Both of these loci were contained within a large congenic interval, originally termed as Sle3 that strongly impacts a variety of myeloid and T-cell phenotypes and mediates fatal lupus nephritis when combined with Sle1. We have now produced two subcongenic strains, B6.Sle3 and B6.Sle5, carrying the Sle3 and Sle5 intervals separately and characterized their phenotypes as monocongenic strains and individually in combination with Sle1. Neither B6.Sle3 nor B6.Sle5 monocongenic strain develop severe autoimmunity; however, both of these intervals cause the development of severe glomerulonephritis when combined with Sle1. Thus, B6.Sle1Sle3 and B6.Sle1Sle5 exhibit splenomegaly, expansion of activated B and CD4 þ T-cell populations and high levels of IgG and IgM autoantibodies targeting multiple nuclear antigens, intact glomeruli and various other autoantigens. In addition, B6.Sle1Sle3 mice also produced higher levels of IgA antinuclear autoantibodies, which were implicated in the development of IgA nephropathy. Our results indicate that Sle3 and Sle5 can independently complement with Sle1, through shared and unique mechanisms, to mediate the development of severe autoimmunity.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by antinuclear antibody (ANA)-mediated end-organ damage. 1, 2 Due to the complexity of genetic factors contributing to the pathogenesis of lupus, congenic dissection of lupus-prone mouse strains has been utilized to determine the immunologic mechanisms leading to its development. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Genetic linkage analysis of a lupus-prone strain, NZM2410, has indicated that development of lupus is a multistep process. 2 Three major non-major histocompatibility complex genomic intervals, Sle1 (on chromosome 1), Sle2 (on chromosome 4) and Sle3/5 (on chromosome 7, originally known as Sle3), were identified in this particular model. 15 Functional analyses of congenic strains carrying Sle1, Sle2 or Sle3/5 have demonstrated that each interval is responsible for different component phenotypes. 5, 6, 8, 12, 14 Among them, the breach of immune tolerance to nuclear antigens mediated by Sle1 is essential for the initiation of lupus development. 9 However, Sle1 by itself does not lead to the development of fatal lupus, and it only mediates severe glomerulonephritis (GN) when combined with either Sle2, Sle3/5, Yaa or lpr. 7, 9, 16 Studies of these lupus susceptibility intervals support a multistep pathogenesis model, in which development of fatal lupus is initiated by Sle1 and exacerbated by various other susceptibility loci or genes. 2 The original linkage analysis defined a single locus (termed Sle3) into a relatively large support area in the centromeric half of chromosome 7. Subsequently, a second larger linkage study identified two separate susceptibility loci within this segment of chromosome 7. 17 These loci were identified as Sle5, which predominantly impacted autoantibody production and mapped close to the centromere of chromosome 7, and Sle3, which mapped near the pink-eye dilution locus and impacted predominantly the severity of GN. The original B6-congenic strain that was produced contained both of these NZM2410-derived loci and is now termed as B6.Sle3/5. 12, 15 It spans about a 45-cM region beginning at or near the centromere and terminating just distal to D7Mit40. Phenotypic characterization of the B6.Sle3/5 strain demonstrated that this interval mediates an elevated CD4/CD8 ratio with an increase in activated CD4 þ T cells, decreased susceptibility to activation-induced cell death and a break in humoral tolerance. 8 Subsequent analyses suggested that the susceptibility alleles(s) within the Sle3/5 interval are expressed in a bone marrow-derived, non-lymphocyte population in the thymus as well as periphery, and can affect T-cell selection and/or survival. 18 B6.Sle3/5 mice develop only low levels ANA and a low penetrance of GN in aged mice of either gender. However, combination of this interval with Sle1 on B6 background resulted in the development of highly penetrant severe GN. 7 To identify the contribution of each individual subinterval to lupus pathogenesis, we generated subcongenic strains, B6.Sle3 and B6.Sle5, which provided useful tools for dissecting the component phenotypes mediated individually by these loci. Our studies indicate that Sle3 and Sle5 can interact independently with Sle1 to mediate earlier expansion of activated B220 þ and CD4 þ T-cell populations, accelerated autoimmunity and highly penetrant severe GN.
Results
Combining either Sle3 or Sle5 with Sle1 mediates severe glomerulonephritis Previous studies have demonstrated that the combination of Sle1 and Sle3/5 in the B6.Sle1Sle3/5 bicongenic leads to severe GN (490% penetrance) with a mortality of B60% by 12 months of age. 7 To determine the individual contributions of Sle3 and Sle5 to the development of severe GN, we first generated the subcongenic strains, B6.Sle3 and B6.Sle5, and then bred each of these loci separately onto B6.Sle1 to generate new bicongenic strains, B6.Sle1Sle3 and B6.Sle1Sle5, carrying Sle1 and Sle3 or Sle5 on B6 background, respectively ( Figure 1 ). Analyses of these new strains revealed striking effects of Sle3 and Sle5 on the pathogenesis mediated by Sle1. Both Sle1Sle3 and Sle1Sle5 developed severe GN (grades 3-4) with penetrance of 90% by 9 months of age. In contrast, neither B6.Sle3 nor B6.Sle5 mice developed severe GN. Only a low percentage (30%) of B6.Sle1 developed GN that was scored as 3 or higher ( Figure 2 ). Both Sle3 and Sle5 accelerate Sle1-mediated autoimmune phenotypes While splenomegaly has been shown to be prominent in B6.Sle1 mice, B6.Sle3/5 mice do not display significant splenomegaly. 8 Similarly, B6.Sle3 and B6.Sle5 mice appeared to have normal-sized spleens (data not shown). The independent introduction of Sle3 or Sle5 onto the B6.Sle1 mice resulted in more pronounced splenomegaly than B6.Sle1 mice (Figure 3a) . To determine whether Sle3 and Sle5 affect ANA production, a key feature of the autoimmune phenotypes in NZM2410 lupus model, we analyzed the IgG ANA levels in B6.Sle1Sle3 and B6.Sle1Sle5 mice. Although Sle3 and Sle5 produced very low levels of ANA (data not shown), the combination of Sle1 with either Sle3 or Sle5 led to a much earlier onset of ANA production. At the age of 3 months, the levels of IgG ANA were already significantly higher in B6.Sle1Sle3 and B6.Sle1Sle5 than in B6.Sle1, most notably in B6.Sle1Sle3 mice (Figures 3b and c) . Sle1 was known to mediate the breach of immune tolerance to nuclear antigens, 5 and in the older B6.Sle1 mice, the antinuclear autoantibodies also reached high levels, as shown in Figures 3d and e. At 9 months of age, the levels of antidsDNA and antihistone antibodies were comparable to those in B6.Sle1Sle3 and B6.Sle1Sle5 mice. In view of the significant difference in severity of kidney pathology between B6.Sle1 and the bicongenic mice, we also compared the presence of antibodies against other autoantigens in these mice, as described below.
Combination of Sle3 or Sle5 with Sle1 mediates the production of autoantibodies targeting a broader spectrum of autoantigens Spreading of autoreactive B-cell responses has been demonstrated to be associated with human and murine lupus. [19] [20] [21] [22] [23] [24] [25] Based on our initial observation that combina-
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B6 B6 Figure 1 Derivation of B6.Sle3, B6.Sle5, B6.Sle1Sle3 and B6.Sle1Sle5 mouse strains. B6.Sle1 and B6.Sle3/5 were generated from NZM2410 lupus-prone strain. 14 (a) Localization of Sle3 and Sle5. B6.Sle3/5 was backcrossed to B6 and the progenies were screened for recombinants with truncated Sle3/5 interval. Two subcongenic strains, Sle3 and Sle5, were selected based on the results of linkage analysis (see Materials and methods). Sle3 interval is flanked by D7Mit306 and D7Mit154, and Sle5 is flanked by D7Mit157 and D7Mit40. (b) B6 congenics bearing NZM2410-derived lupus susceptibility intervals. B6.Sle1, B6.Sle3 and B6.Sle5 are congenic for Sle1, Sle3 and Sle5, respectively. B6.Sle1Sle3 are congenic for Sle1 and Sle3, while B6.Sle1Sle5 are congenic for Sle1 and Sle5.
Sle3 and Sle5 accelerate autoimmunity K Liu et al tion of Sle1 with Sle3 or Sle5 led to highly penetrant severe lupus nephritis (Figure 2) , we analyzed the reactivities of sera from these strains to the antigens expressed on glomeruli using autoantigen array hybridization. This type of array contained about 40 antigens known to be expressed on glomeruli, and offered a rapid overview of the serum's reactivity. Sera of ten 9-monthold mice from each group were analyzed, and cluster analyses of the results are shown in Figures 4a and 5a . Sera from B6.Sle3 and B6.Sle5 reacted only weakly with some of these antigens. In contrast, sera from B6.Sle1, B6.Sle1Sle3 and B6.Sle1Sle5 showed strong reactivity to many of these antigens. Although sera from B6.Sle1, B6.Sle1Sle3 and B6.Sle1Sle5 mice had high levels of IgG antibodies targeting most autoantigens on the array, overall, B6.Sle1Sle3 and B6.Sle1Sle5 mice had more IgG autoantibodies targeting more of these autoantigens than B6.Sle1 mice (Figures 4a and b) . In these three strains of mice, highest levels of IgG autoantibodies were observed in B6.Sle1Sle3 mice. Besides showing a higher penetrance of IgG autoantibodies than B6.Sle1 mice, B6.Sle1Sle5 mice also had strikingly higher penetrance of IgM autoantibodies (Figures 5a and b) . Not surprisingly, B6.Sle1Sle3 mice have higher levels of total IgG, while B6.Sle1Sle5 mice have higher levels of total IgM (Figures 4c and 5c ). Undoubtedly, increased autoantibody levels contribute to the elevation of total Ig levels; however, different autoantibody levels do not necessarily reflect the different levels of total Ig. For instance, in Figure 5 , although the penetrance of IgM autoantibodies in B6.Sle1Sle5 mice are much higher than those in B6.Sle1Sle3 mice (P ¼ 0.0001), the difference in their total IgM levels is mild (P ¼ 0.055). Therefore, the observed reactivity is, at least in part, contributed by activation of specific autoimmune clones.
Combination of Sle3 with Sle1 mediates elevated IgA autoantibody production Since B6.Sle1Sle3 mice produce high levels of IgG autoantibodies, we speculated that further class switching from these IgG autoantibodies to IgA could also occur. Consistent with this expectation, we found that the levels of IgA autoantibodies targeting dsDNA and histone were significantly higher in B6.Sle1Sle3 mice, while they were only slightly higher in B6.Sle1 and B6.Sle1Sle5 mice than in age-matched control B6 mice Both Sle3 and Sle5 accelerate the Sle1-mediated expansion of activated CD4 þ T lymphocytes and B lymphocytes Previous studies identified an expansion of activated CD4 þ T cells (CD69 þ ) in B6.Sle1 mice. 5 In this study, we have found that both Sle3 and Sle5 can accelerate this phenotype. As shown in Figures 7a and 8b, a significantly higher percentage of CD4 þ T cells were CD69 þ in B6.Sle1Sle5 mice as well as B6.Sle1Sle3 mice than in B6.Sle1 mice at 3-4 months of age. Although Sle1 was also demonstrated to mediate dysregulated B-cell activation, 5 it was not detectable at very young age. In this study, the expansion of activated B lymphocytes appeared to be more pronounced and earlier in B6.Sle1Sle5 mice, as measured by CD69 and major histocompatibility complex class II staining (Figures 7c and e) . All of these phenotypes were At least two lupus susceptibility loci are present in Sle3 interval B6.Sle3 carries an B25 cM genomic interval derived from NZM2410 ( Figure 1 ). During the initial derivation of these truncated congenics, two variants of the telomeric segment containing Sle3 were produced ( Figure 8a ). As shown in Figure 8 , when the full-length Sle3 interval and the truncated Sle3(158-40) interval are combined with Sle1 on B6 background, different phenotypes were observed. Although both of these bicongenic strains displayed expansion of activated CD4 þ T cells, only B6.Sle1Sle3 strain showed significant expansion of activated B cells at 3 months of age (Figures 8b-d) . These results suggest that at least two susceptibility loci exist in this region, with one affecting T-cell activation 
Discussion
Although it had been established that the combination of Sle1 and Sle3/5 on the B6 background causes the development of severe lupus, the individual contributions of Sle3 and Sle5 to this phenotype were unknown. This is the first demonstration that both Sle3 and Sle5 can interact individually with Sle1 to mediate severe lupus nephritis. Their contribution to lupus pathogenesis involves accelerated expansion of activated CD4 þ T cells and B cells, broadened spectrum of autoantigens recognized by autoantibodies, and, in the case of Sle3, elevated production of IgA antinuclear antibodies. Although this study does not exclude the possibility that the genomic region between Sle3 and Sle5 could also contribute to lupus pathogenesis mediated by Sle3/5 full interval, it has clearly confirmed that Sle3 and Sle5 are two strong lupus susceptibility loci, as predicted by the original linkage analyses. Sle3 and Sle5 accelerate autoimmunity
The disease phenotypes of B6.Sle1Sle3 and B6.Sle1Sle5 share some common features with other murine lupus models, including increased antinuclear IgG production, accelerated splenomegaly and expansion of activated CD4 þ T-and B lymphocytes. These processes appear to be essential elements in the development of severe lupus nephritis, indicating that an expansion of the antigen spectrum and frequency of activated CD4 þ T cells and B cells are important in the development of pathogenic systemic autoimmunity.
Although it has been well documented that Sle1 also mediates expanded population of activated CD4 þ T cells and B cells, the expansion occurred much earlier in B6.Sle1Sle3 and B6.Sle1Sle5 mice than in B6.Sle1 monocongenic mice (Figures 7 and 8) . Therefore, it could, at least in part, account for the observed differences in disease severity. Consistent with the early cellular phenotypes, these bicongenic mice also develop higher levels of antinuclear antibodies at very young ages (Figure 3) . Furthermore, this study also presents a Sle3 and Sle5 accelerate autoimmunity K Liu et al powerful strategy for continuing fine mapping of these two loci by analyzing these early phenotypes. Although both Sle3 and Sle5 can interact with Sle1 to mediate severe lupus nephritis, the mechanisms involved are not exactly the same. Most interestingly, the two bicongenic strains, B6.Sle1Sle3 and B6.Sle1Sle5, displayed distinct serological phenotypes. Even though both developed high levels of antinuclear antibodies, B6.Sle1Sle3 mice produced more IgG autoantibodies targeting a broad spectrum of self-antigens expressed in the kidney. While B6.Sle1Sle5 mice also produced more IgG autoantibodies than B6.Sle1 mice, they showed significantly higher levels of IgM antinuclear autoantibodies. These results clearly indicate that Sle3 and Sle5 accelerate Sle1-mediated autoimmunity by separate mechanisms. By the autoantigen array analyses, we also observed the variability in spectrum of autoantigens recognized by sera from different individual mice of the same strain (Figures 4a and 5a) . It has been demonstrated that expression of Sle1 is responsible for the increased survival of autoreactive B-cell clones. 26, 27 Addition of Sle3 and Sle5 may further lower the threshold for B-cell activation and increase the tendency for autoreactive B cells to proliferate/differentiate upon stimulation by autoantigens. Therefore, the variability of antigen reactivity in different mice of the same strain may be in part due to the stochastic encounters of these B-cell clones with different autoantigens.
IgM autoantibodies from B6.Sle1Sle5 mice targeted a broader spectrum of autoantigens and contributed significantly to the immune complex deposits in kidneys, which provide an important insight into the mechanism ultimately leading to kidney damage in this lupus-prone mouse model. The potential importance of IgM auto- Sle3 and Sle5 accelerate autoimmunity K Liu et al antibodies in murine lupus nephritis has also been reported by other investigators. 28 In the case of (NZB Â NZW)F1 mice, it was reported that the earliest lesions in kidneys were confined to the mesangium associated mainly with IgM deposits, and to a lesser degree with IgG. 28 More recently, an NZB locus on chromosome 4, Lbw2, has been shown to enhance B-cell reactivity as well as autoantibody production, and lack of Lbw2 in BWF1 mice led to reduced IgM Ab level as well as reduced mortality and GN, but not serum levels of total and anti-DNA IgG Abs. 29 Although IgM ANA may play an important role in Sle1Sle5-mediated lupus nephritis, one should keep in mind that B6.Sle1Sle5 mice also have high level of IgG ANA. Therefore, the development of severe GN is likely the additive result of IgG and IgM ANAs.
In contrast to B6.Sle1Sle5 mice, B6.Sle1Sle3 mice did not show the increase in IgM ANA over B6.Sle1 mice. However, these mice produced higher levels of IgG autoantibodies targeting more autoantigens. Similar to B6.Sle1Sle5 mice, B6.Sle1Sle3 mice revealed more activated CD4 þ T cells and B cells. In spite of this, B6.Sle1Sle3 mice produced more IgG than B6.Sle1Sle5 mice, suggesting that Sle3 is more effective in mediating Ig class switching to IgG, and that Sle5 plays more roles in accelerating B-cell activation. Although it has been identified previously that an NZW Cd22 allelic variant located in the centromeric part of chromosome 7 predisposes to lupus susceptibility, 30 this gene does not reside within Sle3 or Sle5 intervals (Figure 1a) .
Besides producing more IgG ANA, B6.Sle1Sle3 mice also produced marginally increased IgA ANA. Theoretically, Ig class switching to IgA can occur in at least two different ways. First, the switch can take place from IgM directly to IgA. Second, the switch can also be accomplished from IgG to IgA. Given the fact that B6.Sle1Sle3 have higher levels of IgG ANA, both of these two events can exist in these mice. In fact, IgA autoantibodies are also detected in some SLE patients. 31, 32 Therefore, B6.Sle1Sle3 strain may provide a unique model for studying lupus. The detailed mechanisms by which combination of Sle1 and Sle3 mediates more IgA production remain to be investigated. Although B6.Sle1Sle3 did not show high levels of IgM autoantibodies, immunofluorescence staining did show the deposition of IgM in kidneys of these mice. This may be due to the combination of several factors, including nephritis that already occurred, large size of IgM molecules and elevated levels of total IgM (Figure 5c) , and so on. The precise mechanism for this observation remains to be elucidated.
Sle3 is a relatively long genomic interval (B25 cM), and it is not surprising that it contains more than one lupus susceptibility locus. Current data support the hypothesis that this interval contains at least two lupus susceptibility loci, with one mediating stronger CD4 þ Tcell activation and the other enhancing ANA production. The effect of the full Sle3 interval can also result from the combination of both susceptibility loci in this region, and the phenotypes (accelerated CD4 þ T-and B-cell activation) can be due to either the intrinsic defect in these cell populations or extrinsic effects of other interactive cells. In fact, it has been indicated that the hyperactivity of CD4 þ T cells mediated by Sle3 could be due to the intrinsic abnormalities in dendritic cells and other myeloid cells. 33 The speculation that a locus responsible for enhancing ANA production exists in the interval from D7Mit157 to D7Mit158 is based on the phenotypic analyses performed on B6.Sle3 and B6.Sle3(158-40) strains. However, direct evidence can only be obtained from the analyses of B6.Sle3(157-158) mice. It would be interesting to see whether Sle3(157-158) by itself can interact with Sle1 to mediate enhanced IgG ANA production. We are now in the process of generating this strain. Undoubtedly, future studies on these three strains will help dissect further the mechanisms by which Sle3 mediates accelerated autoimmunity. The results we have obtained so far indicate that Sle3 mediates not only CD4 þ T-cell phenotype (hyperactivation) but also B-cell phenotype (hyperactivation and enhanced ANA production), and that interaction between Sle1 and Sle3 can lead to the development of severe lupus nephritis.
Precise and detailed depiction of the mechanisms by which Sle3 and Sle5 accelerate Sle1-mediated systemic autoimmunity will rely on identification and characterization of the disease genes within these intervals. Further fine mapping of these susceptibility loci is underway, and phenotypic analyses presented in this report are serving as powerful guides in this process. We anticipate that these analyses will help to pinpoint the responsible genes within these susceptibility loci.
Materials and methods
Mice B6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA) and subsequently bred in the University of Texas Southwestern Medical Center Specific Pathogen-free animal colony. The derivation of B6 congenic mice, B6.Sle1 and B6.Sle3/5, bearing NZM2410-derived lupus susceptibility intervals has been detailed previously.
14 As depicted in Figure 1 , B6.Sle3 mice are B6 mice congenic (homozygotes) for an B20-cM interval containing pink-eyed dilution locus on murine chromosome 7, while B6.Sle5 mice are B6 mice congenic (homozygotes) for an B2-cM interval proximal to the centromeric end on the same chromosome. The B6.Sle3 and B6.Sle5 mouse strains were produced by crossing B6.Sle3/5 heterozygotes to B6 to generate a series of recombinant progeny. The progeny carrying the subintervals from D7Mit157 to D7Mit40 (for Sle3) or from D7Mit306 to D7Mit154 (for Sle5) were chosen based on original mapping study 15, 17 and backcrossed to B6 again to generate mice carrying this specific subinterval. These mice were then intercrossed to produce the mice homozygous for these subintervals, and the newly generated strains were designated as B6.Sle3 and B6.Sle5, respectively. B6.Sle1Sle3 and B6.Sle1Sle5 mice, bicongenic for Sle1 and Sle3 or Sle1 and Sle5, were derived by intercrossing the monocongenic strains and breeding for mice that were homozygous across both susceptibility intervals. All mice used for this study were bred and housed in the specific pathogen-free animal colony. All experiments were carried out with the approval of the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center.
Histopathology
Mice were killed at 9 months of age. Three-micrometer sections of formalin-fixed, paraffin-embedded kidney tissues were cut and stained with hematoxylin and eosin and periodic acid-Schiff. These sections were examined in a blinded fashion, for any evidence of pathology in the glomeruli, tubules or interstitial areas, as described before. The glomeruli were screened for evidence of hypertrophy, proliferative changes, crescent formation, hyaline deposits, fibrosis/sclerosis and basement membrane thickening. Fifteen to twenty high-power fields at Â 200 magnification were examined for each sample. The severity of GN was graded on a 0-4 scale as follows: 0, normal; (1) mild increase in mesangial cellularity and matrix; (2) moderate increase in mesangial cellularity and matrix, with thickening of the glomerular basement membrane; (3) focal endocapillary hypercellularity with obliteration of capillary lumina and a substantial increase in the thickness and irregularity of the glomerular basement membrane; and (4) diffuse endocapillary hypercellularity, segmental necrosis, crescents and hyalinized end-stage glomeruli. GN of grades 3-4 is referred as 'severe GN'. Immunofluorescence analysis of IgA deposition in kidneys was performed on 3-mm cryostat sections as described previously. 34 Fluorescein isothiocyanate-labeled rabbit antibodies against mouse IgA were purchased from MP Biomedicals (Solon, OH, USA).
Enzyme-linked immunosorbent assay for autoantibodies
The anti-dsDNA, antihistone and antihistone/DNA enzyme-linked immunosorbent assays were performed as described previously. 7 For the anti-dsDNA enzymelinked immunosorbent assay, Immulon II plates (Dynatech, Chantilly, VA, USA) precoated with methylated bovine serum albumin were coated overnight with 50 mg ml À1 dsDNA (Sigma-Aldrich, St Louis, MO, USA, dissolved in phosphate-buffered saline, and filtered through cellulose acetate before use). For the antihistone enzyme-linked immunosorbent assay, the plates were coated with 10 mg ml À1 of 'total' histones (a mixture of all histones, purchased from Boehringer Mannheim, Indianapolis, IN, USA) overnight at 4 1C. After blocking with phosphate-buffered saline/3% bovine serum albumin/ 0.1% gelatin/3 mM ethylenediaminetetraacetic acid, 1:100 (starting) dilutions of the test sera were incubated in duplicate for 2 h at room temperature. Bound IgG was detected with alkaline phosphatase-conjugated antimouse IgG (Jackson Immunoresearch Laboratory, West Grove, PA, USA), using p-nitrophenyl phosphate as a substrate. Raw optical density was converted into U ml À1 using a serum from an NZM2410 mouse, arbitrarily setting the reactivity of a 1:100 dilution of this serum to 100 U ml
À1
.
Autoantigen array hybridization
Reactivity of mouse sera to glomerular autoantigens spotted on autoantigen arrays were determined following the protocol described previously. 35 One hundred microliters of the diluted (1:100) DNase-treated serum sample was applied to the autoantigen array for hybridization. Cy3-or Cy5-labeled anti-IgM and antiIgG detection Abs (5 mg ml
À1
, Jackson Immunoresearch) were used to generate signals specific for IgM and IgG, respectively, when the arrays were scanned using a Genepix 4000 B scanner. Cy3 signal was scanned at 532 nM, and the Cy5 signal was scanned at 635 nM. All fluorescence intensities were normalized using mouse total IgG/IgM (Sigma, St Louis, MO, USA) spotted onto the same slide, to derive 'normalized fluorescence intensity' (nfi) units. For each antigen, data obtained from duplicate spots were averaged prior to any statistical comparisons.
Flow cytometry
Flow cytometry analysis was performed as described previously. 4 Briefly, cells were first blocked with staining medium (phosphate-buffered saline, 2% fetal calf serum and 0.05% azide) containing Fc block. Cells were then stained on ice with optimal amounts of FITC, phycoerythrin, PerCP-Cy5.5 or APC-conjugated primary antibodies diluted in staining medium for 30 min. The following dye-or biotin-coupled antibodies were obtained from BD PharMingen (San Diego, CA, USA): CD4 (H129.19), CD45R/B220 (RA3-6B2), CD69 (H1.2F3) and I-A/I-E (2G9). These antibodies were used at pretitrated dilutions. Cell staining was analyzed using a FACS Calibur (BD Immunocytometry Systems, San Jose, CA, USA). Forty thousand events were acquired per sample. The data were analyzed with FlowJo software (Tree Star, Ashland, OR, USA).
Statistics
Data were analyzed using parametric analysis of variance s as determined by InStat3 (Graphpad Software) unless otherwise indicated. Results are expressed as the mean7s.e. and differences were considered significant at Po0.05.
